| Sandoz Pharmaceuticals AG - Lisitril 5, Tabletten |
| 56061 | | 01 | | Lisitril 5 | | Tabletten | | C09AA03 | | Lisinopril | | 02.09.2003 | | |
|
| Composition |
| lisinoprilum 5 mg ut lisinoprilum dihydricum, calcii hydrogenophosphas dihydricus, mannitolum, maydis amylum, carmellosum natricum conexum corresp. natrium 0.18 mg, magnesii stearas, E 172 (rubrum), pro compresso. |
| Packungsbestandteile |
| Tabletten | | | | | Principe actif | Concentr. |
|---|
| Lisinopril | 5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lisinopril | 5 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Rubrum) | | | | Calcium Hydrogenophosphat Dihydrat | | | | Carmellosum Natricum Conexum | | | | E 172 | | color. | | Magnesii Stearas | | | | Mannitol | | | | Maydis Amylum | | | | Pro Compresso | | |
| |
|
| couper ou écraser |
| | Ja | | | | Ja (innert 5-15 min in 30 ml Wasser) | | | | Ja | | | | -- | | | | Sondenapplikation: Tablette mörsern und in 10 ml Wasser suspendieren, gut ausspülen | | | | | |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 30 Tablette(n) | 2.53 | 12.00 | B | LS | Oui | | 004 | 100 Tablette(n) | 6.25 | 16.05 | B | LS | Oui |
|
